Returned to operating profitability with $7.6M in income from operations.
Consolidated gross margin increased to 48.3% from 44.3% YoY.
Acquired Canary Connect and Aloe Care Health to expand AI and healthcare footprint.
Initiated $50M stock repurchase program with $8M already executed.
The Q1 2026 filing presents a company in the midst of a high-stakes transition. On one hand, the acceleration of subscription revenue and the move toward positive operating income suggest that Arlo's long-term strategy of monetizing its installed base is working. The shift in revenue mix toward high-margin services provides a clearer path to sustainable profitability than the company has ever had. However, the persistence of negative margins in the hardware segment and the heavy reliance on a single major customer create a precarious balance. Investors must weigh the excitement of the AI-driven healthcare expansion against the reality of a business that is still burning cash on its physical product line. The overall impact of the filing is a mixed signal: the growth engine is firing, but the structural weaknesses of the legacy hardware business remain unresolved.